As many biotech investors noticed, shares of Affymax (AFFY) exploded yesterday, up 54%, with an unheard of amount of trading volume. In this video, Motley Fool health-care analyst David Williamson unwinds some of the rumors that may have led to this stock's jump, and warns investors that taking a position in this stock right now isn't investing, it's gambling, and you may be betting on a very shaky horse.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Steer Clear of Affymax's Mysterious Pop
OTC: AFFY
Affymax, Inc.

This is a rocket ride you want no part of.
David Williamson has no position in any stocks mentioned. Follow him on Twitter: @MotleyDavid.
The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned





*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.